The new investment — which comes from 17 health systems, Illumina, and Regeneron — pushes Truveta’s valuation above $1 billion, making it the latest unicorn to emerge from the Seattle region.

While actions taken against certain FinTech players, I think it's a very clear message to all NBFCs to clean up their books and get their acts together There has always been a constant slugfest ...